The Familial Parkinsonism Gene LRRK2 Regulates Neurite Process Morphology

Neuron

Volumn 52, Issue 4, 2006, Pages 587-593

  MacLeod, David ^a   Dowman, Julia ^a   Hammond, Rachel ^a   Leete, Thomas ^a   Inoue, Keiichi ^a   Abeliovich, Asa ^a  

^a NewYork Presbyterian Hospital   (United States)

Author keywords

HUMDISEASE; MOLNEURO; SIGNALING

Indexed keywords

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; CELL SHAPE; CELLS, CULTURED; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCLUSION BODIES; LYSOSOMES; MICE; MUTATION; NERVE DEGENERATION; NEURITES; PARKINSONIAN DISORDERS; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA; TAU PROTEINS;

EID: 33751256567     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuron.2006.10.008     Document Type: Article

References (17)

1. Abeliovich A., and Beal M.F. Parkinsonism genes: culprits and clues. J. Neurochem. 99 (2006) 1062 10.1111/j.1471-4159.2006.04102.x
2. Arantes R.M., and Andrews N.W. A role for synaptotagmin VII-regulated exocytosis of lysosomes in neurite outgrowth from primary sympathetic neurons. J. Neurosci. 26 (2006) 4630-4637
3. Cobb M.H., and Goldsmith E.J. How MAP kinases are regulated. J. Biol. Chem. 270 (1995) 14843-14846
4. Davies H., Bignell G.R., Cox C., Stephens P., Edkins S., Clegg S., Teague J., Woffendin H., Garnett M.J., Bottomley W., et al. Mutations of the BRAF gene in human cancer. Nature 417 (2002) 949-954
5. Gloeckner C.J., Kinkl N., Schumacher A., Braun R.J., O'Neill E., Meitinger T., Kolch W., Prokisch H., and Ueffing M. The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum. Mol. Genet. 15 (2005) 223-232
6. Kirik D., Rosenblad C., Burger C., Lundberg C., Johansen T.E., Muzyczka N., Mandel R.J., and Bjorklund A. Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system. J. Neurosci. 22 (2002) 2780-2791
7. Manning G., Whyte D.B., Martinez R., Hunter T., and Sudarsanam S. The protein kinase complement of the human genome. Science 298 (2002) 1912-1934
8. Martinat C., Bacci J.J., Leete T., Kim J., Vanti W.B., Newman A.H., Cha J.H., Gether U., Wang H., and Abeliovich A. Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc. Natl. Acad. Sci. USA 103 (2006) 2874-2879
9. Martinez-Arca S., Coco S., Mainguy G., Schenk U., Alberts P., Bouille P., Mezzina M., Prochiantz A., Matteoli M., Louvard D., and Galli T. A common exocytotic mechanism mediates axonal and dendritic outgrowth. J. Neurosci. 21 (2001) 3830-3838
10. Paisan-Ruiz C., Jain S., Evans E.W., Gilks W.P., Simon J., van der Brug M., de Munain A.L., Aparicio S., Gil A.M., Khan N., et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44 (2004) 595-600
11. Staropoli J.F., McDermott C., Martinat C., Schulman B., Demireva E., and Abeliovich A. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37 (2003) 735-749
12. Troy C.M., Greene L.A., and Shelanski M.L. Neurite outgrowth in peripherin-depleted PC12 cells. J. Cell Biol. 117 (1992) 1085-1092
13. Tsai J.W., Chen Y., Kriegstein A.R., and Vallee R.B. LIS1 RNA interference blocks neural stem cell division, morphogenesis, and motility at multiple stages. J. Cell Biol. 170 (2005) 935-945
14. West A.B., Moore D.J., Biskup S., Bugayenko A., Smith W.W., Ross C.A., Dawson V.L., and Dawson T.M. Parkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc. Natl. Acad. Sci. USA 102 (2005) 16842-16847
15. Wszolek Z.K., Pfeiffer R.F., Tsuboi Y., Uitti R.J., McComb R.D., Stoessl A.J., Strongosky A.J., Zimprich A., Muller-Myhsok B., Farrer M.J., et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 62 (2004) 1619-1622
16. Xia Z., Dudek H., Miranti C.K., and Greenberg M.E. Calcium influx via the NMDA receptor induces immediate early gene transcription by a MAP kinase/ERK-dependent mechanism. J. Neurosci. 16 (1996) 5425-5436
17. Zimprich A., Biskup S., Leitner P., Lichtner P., Farrer M., Lincoln S., Kachergus J., Hulihan M., Uitti R.J., Calne D.B., et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44 (2004) 601-607